Report Detail

Pharma & Healthcare Global Parkinson's Disease Drug Market Professional Survey Report 2018

  • RnM2139873
  • |
  • 06 July, 2020
  • |
  • Global
  • |
  • 149 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Parkinson's Disease Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Parkinson's Disease Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Parkinson's Disease Drug Market Size Growth Rate by Type
    • 1.4.2 Sinemet-CR
    • 1.4.3 Trastal
    • 1.4.4 Madopar
    • 1.4.5 COMT Inhibitor
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global Parkinson's Disease Drug Market Size Growth Rate by Application
    • 1.5.2 Under 40 Years Old
    • 1.5.3 40-65 Years Old
    • 1.5.4 Above 65 Years Old
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Parkinson's Disease Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Parkinson's Disease Drug Revenue 2015-2026
    • 2.1.2 Global Parkinson's Disease Drug Sales 2015-2026
  • 2.2 Global Parkinson's Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Parkinson's Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Parkinson's Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Parkinson's Disease Drug Competitor Landscape by Players

  • 3.1 Parkinson's Disease Drug Sales by Manufacturers
    • 3.1.1 Parkinson's Disease Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Parkinson's Disease Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Parkinson's Disease Drug Revenue by Manufacturers
    • 3.2.1 Parkinson's Disease Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Parkinson's Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Parkinson's Disease Drug Revenue in 2019
    • 3.2.5 Global Parkinson's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Parkinson's Disease Drug Price by Manufacturers
  • 3.4 Parkinson's Disease Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Parkinson's Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Parkinson's Disease Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Parkinson's Disease Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Parkinson's Disease Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Parkinson's Disease Drug Sales by Type (2015-2020)
    • 4.1.2 Global Parkinson's Disease Drug Revenue by Type (2015-2020)
    • 4.1.3 Parkinson's Disease Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Parkinson's Disease Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Parkinson's Disease Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Parkinson's Disease Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Parkinson's Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Parkinson's Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Parkinson's Disease Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Parkinson's Disease Drug Sales by Application (2015-2020)
    • 5.1.2 Global Parkinson's Disease Drug Revenue by Application (2015-2020)
    • 5.1.3 Parkinson's Disease Drug Price by Application (2015-2020)
  • 5.2 Parkinson's Disease Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Parkinson's Disease Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Parkinson's Disease Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Parkinson's Disease Drug Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Parkinson's Disease Drug by Country
    • 6.1.1 North America Parkinson's Disease Drug Sales by Country
    • 6.1.2 North America Parkinson's Disease Drug Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Parkinson's Disease Drug Market Facts & Figures by Type
  • 6.3 North America Parkinson's Disease Drug Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Parkinson's Disease Drug by Country
    • 7.1.1 Europe Parkinson's Disease Drug Sales by Country
    • 7.1.2 Europe Parkinson's Disease Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Parkinson's Disease Drug Market Facts & Figures by Type
  • 7.3 Europe Parkinson's Disease Drug Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Parkinson's Disease Drug by Region
    • 8.1.1 Asia Pacific Parkinson's Disease Drug Sales by Region
    • 8.1.2 Asia Pacific Parkinson's Disease Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Parkinson's Disease Drug Market Facts & Figures by Type
  • 8.3 Asia Pacific Parkinson's Disease Drug Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Parkinson's Disease Drug by Country
    • 9.1.1 Latin America Parkinson's Disease Drug Sales by Country
    • 9.1.2 Latin America Parkinson's Disease Drug Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Parkinson's Disease Drug Market Facts & Figures by Type
  • 9.3 Central & South America Parkinson's Disease Drug Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Parkinson's Disease Drug by Country
    • 10.1.1 Middle East and Africa Parkinson's Disease Drug Sales by Country
    • 10.1.2 Middle East and Africa Parkinson's Disease Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Parkinson's Disease Drug Market Facts & Figures by Type
  • 10.3 Middle East and Africa Parkinson's Disease Drug Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Description and Business Overview
    • 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck Parkinson's Disease Drug Products Offered
    • 11.1.5 Merck Related Developments
  • 11.2 Akorn
    • 11.2.1 Akorn Corporation Information
    • 11.2.2 Akorn Description and Business Overview
    • 11.2.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Akorn Parkinson's Disease Drug Products Offered
    • 11.2.5 Akorn Related Developments
  • 11.3 GSK
    • 11.3.1 GSK Corporation Information
    • 11.3.2 GSK Description and Business Overview
    • 11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GSK Parkinson's Disease Drug Products Offered
    • 11.3.5 GSK Related Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Corporation Information
    • 11.4.2 Novartis Description and Business Overview
    • 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis Parkinson's Disease Drug Products Offered
    • 11.4.5 Novartis Related Developments
  • 11.5 Boehringer Ingelheim
    • 11.5.1 Boehringer Ingelheim Corporation Information
    • 11.5.2 Boehringer Ingelheim Description and Business Overview
    • 11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Boehringer Ingelheim Parkinson's Disease Drug Products Offered
    • 11.5.5 Boehringer Ingelheim Related Developments
  • 11.6 Teva Pharmaceutical
    • 11.6.1 Teva Pharmaceutical Corporation Information
    • 11.6.2 Teva Pharmaceutical Description and Business Overview
    • 11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Teva Pharmaceutical Parkinson's Disease Drug Products Offered
    • 11.6.5 Teva Pharmaceutical Related Developments
  • 11.7 Abbvie
    • 11.7.1 Abbvie Corporation Information
    • 11.7.2 Abbvie Description and Business Overview
    • 11.7.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Abbvie Parkinson's Disease Drug Products Offered
    • 11.7.5 Abbvie Related Developments
  • 11.8 Kyowa Hakko Kirin Pharma
    • 11.8.1 Kyowa Hakko Kirin Pharma Corporation Information
    • 11.8.2 Kyowa Hakko Kirin Pharma Description and Business Overview
    • 11.8.3 Kyowa Hakko Kirin Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Products Offered
    • 11.8.5 Kyowa Hakko Kirin Pharma Related Developments
  • 11.9 Astellas Pharma
    • 11.9.1 Astellas Pharma Corporation Information
    • 11.9.2 Astellas Pharma Description and Business Overview
    • 11.9.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Astellas Pharma Parkinson's Disease Drug Products Offered
    • 11.9.5 Astellas Pharma Related Developments
  • 11.10 Desitin Arzneimittel
    • 11.10.1 Desitin Arzneimittel Corporation Information
    • 11.10.2 Desitin Arzneimittel Description and Business Overview
    • 11.10.3 Desitin Arzneimittel Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Desitin Arzneimittel Parkinson's Disease Drug Products Offered
    • 11.10.5 Desitin Arzneimittel Related Developments
  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Description and Business Overview
    • 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck Parkinson's Disease Drug Products Offered
    • 11.1.5 Merck Related Developments
  • 11.12 F.Hoffmann-La Roche
    • 11.12.1 F.Hoffmann-La Roche Corporation Information
    • 11.12.2 F.Hoffmann-La Roche Description and Business Overview
    • 11.12.3 F.Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 F.Hoffmann-La Roche Products Offered
    • 11.12.5 F.Hoffmann-La Roche Related Developments
  • 11.13 H.Lundbeck
    • 11.13.1 H.Lundbeck Corporation Information
    • 11.13.2 H.Lundbeck Description and Business Overview
    • 11.13.3 H.Lundbeck Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 H.Lundbeck Products Offered
    • 11.13.5 H.Lundbeck Related Developments
  • 11.14 Valeant
    • 11.14.1 Valeant Corporation Information
    • 11.14.2 Valeant Description and Business Overview
    • 11.14.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Valeant Products Offered
    • 11.14.5 Valeant Related Developments
  • 11.15 Apokyn
    • 11.15.1 Apokyn Corporation Information
    • 11.15.2 Apokyn Description and Business Overview
    • 11.15.3 Apokyn Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Apokyn Products Offered
    • 11.15.5 Apokyn Related Developments
  • 11.16 Orion
    • 11.16.1 Orion Corporation Information
    • 11.16.2 Orion Description and Business Overview
    • 11.16.3 Orion Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Orion Products Offered
    • 11.16.5 Orion Related Developments
  • 11.17 Stada Arzneimittel
    • 11.17.1 Stada Arzneimittel Corporation Information
    • 11.17.2 Stada Arzneimittel Description and Business Overview
    • 11.17.3 Stada Arzneimittel Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Stada Arzneimittel Products Offered
    • 11.17.5 Stada Arzneimittel Related Developments
  • 11.18 US WorldMeds
    • 11.18.1 US WorldMeds Corporation Information
    • 11.18.2 US WorldMeds Description and Business Overview
    • 11.18.3 US WorldMeds Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 US WorldMeds Products Offered
    • 11.18.5 US WorldMeds Related Developments
  • 11.19 Bausch Health
    • 11.19.1 Bausch Health Corporation Information
    • 11.19.2 Bausch Health Description and Business Overview
    • 11.19.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Bausch Health Products Offered
    • 11.19.5 Bausch Health Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Parkinson's Disease Drug Market Estimates and Projections by Region
    • 12.1.1 Global Parkinson's Disease Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Parkinson's Disease Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Parkinson's Disease Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Parkinson's Disease Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Parkinson's Disease Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Parkinson's Disease Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Parkinson's Disease Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Parkinson's Disease Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Parkinson's Disease Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Parkinson's Disease Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Parkinson's Disease Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Parkinson's Disease Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Parkinson's Disease Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Parkinson's Disease Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Parkinson's Disease Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Parkinson's Disease Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Parkinson's Disease Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Parkinson's Disease Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Parkinson's Disease Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Parkinson's Disease Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Parkinson's Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Parkinson's Disease Drug market is segmented into
    Sinemet-CR
    Trastal
    Madopar
    COMT Inhibitor
    Other

    Segment by Application, the Parkinson's Disease Drug market is segmented into
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

    Regional and Country-level Analysis
    The Parkinson's Disease Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Parkinson's Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Parkinson's Disease Drug Market Share Analysis
    Parkinson's Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parkinson's Disease Drug business, the date to enter into the Parkinson's Disease Drug market, Parkinson's Disease Drug product introduction, recent developments, etc.

    The major vendors covered:
    Merck
    Akorn
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Bausch Health


    Summary:
    Get latest Market Research Reports on Parkinson's Disease Drug . Industry analysis & Market Report on Parkinson's Disease Drug is a syndicated market report, published as Global Parkinson's Disease Drug Market Professional Survey Report 2018. It is complete Research Study and Industry Analysis of Parkinson's Disease Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,757.30
    4,135.95
    5,514.60
    3,201.90
    4,802.85
    6,403.80
    423,891.00
    635,836.50
    847,782.00
    286,260.00
    429,390.00
    572,520.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report